Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 1 to 20 of 28

1.
2.

Enhanced transport of a novel anti-HIV agent--cosalane and its congeners across human intestinal epithelial (Caco-2) cell monolayers.

Udata C, Patel J, Pal D, Hejchman E, Cushman M, Mitra AK.

Int J Pharm. 2003 Jan 2;250(1):157-68.

PMID:
12480282
3.

Enantioseparation of novel COX-2 anti-inflammatory drugs by capillary electrophoresis using single and dual cyclodextrin systems.

Calvet C, Cuberes R, Pérez-Maseda C, Frigola J.

Electrophoresis. 2002 Jun;23(11):1702-8.

PMID:
12179991
4.

Nasal absorption enhancement strategies for therapeutic peptides: an in vitro study using cultured human nasal epithelium.

Agu RU, Vu Dang H, Jorissen M, Willems T, Kinget R, Verbeke N.

Int J Pharm. 2002 Apr 26;237(1-2):179-91.

PMID:
11955816
5.

Lowering of sodium deoxycholate-induced nasal ciliotoxicity with cyclodextrins.

Zhang Y, Jiang XG, Yao J.

Acta Pharmacol Sin. 2001 Nov;22(11):1045-50.

6.

Improvement of subcutaneous bioavailability of insulin by sulphobutyl ether beta-cyclodextrin in rats.

Tokihiro K, Arima H, Tajiri S, Irie T, Hirayama F, Uekama K.

J Pharm Pharmacol. 2000 Aug;52(8):911-7.

PMID:
11007061
7.

Enhanced absorption of cyclosporin A by complexation with dimethyl-beta-cyclodextrin in bile duct-cannulated and -noncannulated rats.

Miyake K, Arima H, Irie T, Hirayama F, Uekama K.

Biol Pharm Bull. 1999 Jan;22(1):66-72.

PMID:
9989664
8.
9.

Cyclodextrins in acetazolamide eye drop formulations.

Ammar HO, El-Nahhas SA, Khalil RM.

Pharmazie. 1998 Aug;53(8):559-62.

PMID:
9741064
10.

Absorption enhancers as tools to determine the route of nasal absorption of peptides.

Donnelly A, Kellaway IW, Taylor G, Gibson M.

J Drug Target. 1998;5(2):121-7.

PMID:
9588868
11.

Formation and cell-medium partitioning of autoinhibitory free fatty acids and cyclodextrin's effect in the cultivation of Bordetella pertussis.

Frohlich BT, d'Alarcao M, Feldberg RS, Nicholson ML, Siber GR, Swartz RW.

J Biotechnol. 1996 Feb 28;45(2):137-48.

PMID:
9147447
12.
13.

Drug delivery studies in Caco-2 monolayers. IV. Absorption enhancer effects of cyclodextrins.

Hovgaard L, Brøndsted H.

Pharm Res. 1995 Sep;12(9):1328-32.

PMID:
8570530
14.

Methylated beta-cyclodextrins are able to improve the nasal absorption of salmon calcitonin.

Schipper NG, Verhoef JC, Romeijn SG, Merkus FW.

Calcif Tissue Int. 1995 Apr;56(4):280-2.

PMID:
7767838
16.

A study of the percutaneous absorption-enhancing effects of cyclodextrin derivatives in rats.

Vollmer U, Müller BW, Peeters J, Mesens J, Wilffert B, Peters T.

J Pharm Pharmacol. 1994 Jan;46(1):19-22.

PMID:
8201522
17.

Nasal administration of an ACTH(4-9) peptide analogue with dimethyl-beta-cyclodextrin as an absorption enhancer: pharmacokinetics and dynamics.

Schipper NG, Verhoef JC, De Lannoy LM, Romeijn SG, Brakkee JH, Wiegant VM, Gispen WH, Merkus FW.

Br J Pharmacol. 1993 Dec;110(4):1335-40.

18.

Absorption of recombinant human granulocyte colony-stimulating factor (rhG-CSF) and blood leukocyte dynamics following intranasal administration in rabbits.

Watanabe Y, Matsumoto Y, Yamaguchi M, Kikuchi R, Takayama K, Nomura H, Maruyama K, Matsumoto M.

Biol Pharm Bull. 1993 Jan;16(1):93-5.

PMID:
7690293
19.

Cyclodextrins as nasal absorption promoters of insulin: mechanistic evaluations.

Shao Z, Krishnamoorthy R, Mitra AK.

Pharm Res. 1992 Sep;9(9):1157-63.

PMID:
1409397
20.

Delivery of hormones: some new concepts.

Hermens WA.

Pharm Weekbl Sci. 1992 Aug 21;14(4A):253-7. Review.

PMID:
1437507

Supplemental Content

Support Center